Resources from the same session
New and Emerging Targeted Therapies in Non-EGFR/HER2-Mutant NSCLC
Presenter: J. Remon, FR
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides
Gene Fusion Targets
Presenter: L. Hendriks, NL
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides
ctDNA in the Management on NSCLC Patients
Presenter: K. M. Kerr
Session: Session 5 – Hitting Even More Targets in 2024
Resources:
Slides